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Abstract
Hox genes encode transcription factors, which regulate skeletal patterning and chondrocyte differentiation during the
development of cartilage, the precursor to mature bone. Overexpression of the homeobox transcription factors Hoxc8 and
Hoxd4 causes severe cartilage defects due to delay in cartilage maturation. Matrix metalloproteinases (MMPs), bone
morphogenetic proteins (BMPs) and fibroblastic growth factors (FGFs) are known to play important roles in skeletal
development and endochondral bone formation and remodeling. In order to investigate whether these molecules are
aberrantly expressed in Hoxc8- and/or Hoxd4-transgenic cartilage, we performed quantitative RT-PCR on chondrocytes from
Hox-transgenic mice. Gene expression levels of Bmp4, Fgf8, Fgf10, Mmp9, Mmp13, Nos3, Timp3, Wnt3a and Wnt5a were
altered in Hoxc8-transgenic chondrocytes, and Fgfr3, Ihh, Mmp8, and Wnt3a expression levels were altered in Hoxd4-
transgenic chondrocytes, respectively. Notably, Wnt3a expression was elevated in Hoxc8- and reduced in Hoxd4-transgenic
cartilage. These results suggest that both transcription factors affect cartilage maturation through different molecular
mechanisms, and provide the basis for future studies into the role of these genes and possible interactions in pathogenesis
of cartilage defects in Hoxc8- and Hoxd4-transgenic mice.
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Introduction
Hox genes encode transcription factors that are involved in
patterning the individual elements of the developing skeleton
during the development of cartilage, the precursor to mature bone.
Studies on animals provide evidence that patterning, growth and
differentiation of skeletal elements are affected by mutations in
Hox genes. Later in the process of endochondral ossification, as
cartilage is replaced by bone, patterning defects and abnormal
differentiation manifest in skeletal anomalies and growth defects
[1].
Using a binary transgenic system [2], we have previously shown
that overexpression of the homeobox transcription factors Hoxc8
and Hoxd4 results in severe cartilage defects [3,4], characterized
by delayed maturation, reduced proteoglycan content, accumula-
tion of immature chondrocytes and decreased maturation to
hypertrophy. Vertebral and rib cartilages contain accumulation of
proliferating chondrocytes, indicating that cartilage maturation is
affected by overexpression of Hoxc8 and Hoxd4, respectively. The
cartilage of the ribs is weak and structurally insufficient, resulting
in pulmonary failure and perinatal death [3,4].
Earlier results demonstrated that the cartilage defects induced
by overexpression of Hoxd4 could be rescued by supplementation
of the micronutrient folate during pregnancy. When maternal diets
were supplemented with folic acid, transgenic offspring were found
to have less severe Hoxd4-induced skeletal defects. Alcian Blue
staining of cartilage in ribs and vertebral column was restored by
folate supplementation, and rigidity of the skeleton was improved
[3]. Since folate is required for growth and differentiation of
chondrocytes, the beneficial effect of folate in Hoxd4-transgenic
mice might indicate a local deficiency in folate utilization that
would result from deregulated expression of genes encoding folate
transport proteins or folate metabolic enzymes. Our extensive
qRT-PCR analyses on Hoxc8- and Hoxd4- transgenic animals
revealed no changes in mRNA expression pattern of genes and
enzymes involved in nucleotide synthesis, protein methylation and
DNA methylation related to the folate metabolic pathway [5].
These findings suggested that mechanisms other than the folate
pathway genes themselves are altered in the transgenic cartilage,
and that other cellular or molecular pathways respond to folate
supplementation during cartilage formation.
Our current understanding of chondrogenesis, the earliest phase
of skeletal development, is based on studies in chicken and mice, as
well as knockouts. The formation of most bones in the trunk
skeleton of a vertebrate embryo occurs through endochondral
ossification. In this process, a cartilage model is formed that is then
converted into bone through the action of osteoblasts. This process
involves mesenchymal cell condensation and chondrogenic
differentiation. Chondrocytes undergo stages of proliferation,
prehypertrophy and finally mature to hypertrophy. Blood vessels
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e8978and osteoprogenitor cells invade the cartilage model, which leads
to the formation of trabecular bone. The sequence of this well-
defined order of steps is very important for proper cartilage and
bone formation. Any disruption of this process, such as through
overexpression of the Hoxc8- or Hoxd4-transgenes in our
experimental paradigms, is expected to involve genes that control
the progression of chondrocyte differentiation or the cellular
phenotype of chondrocytes.
This hypothesis led us to further investigate the expression of
genes known to be involved in skeletal development, such as the
transcription factors Sox9, Sox5 and Sox6 [6,7], local regulators of
cartilage differentiation like fibroblast growth factors, hedgehog
proteins, bone morphogenetic proteins, and their respective
receptors [8], as well as Wnt signaling pathway components. We
also included Prl1, a molecule that we had previously identified in
a differential display screen as potentially regulated by Hoxc8 [9]
and effectors in cartilage development, such as the Metalloprotei-
nases and Inhibitors. Our choices were further guided by finding
that the majority of the 37 genes were either not represented or
not consistently detectable in DNA microarray assays of Hox
transgenic cartilage (Kruger et al., manuscript in preparation).
Methods
Transgenic Mice
Transgenic mice were created by the VP16-dependent binary
system [2]; phenotypes and similarities of defects in Hoxd4- and
Hoxc8-transgenic mice have been characterized and published
[3,4]. The binary transgenic system is based on the potent
transcriptional activator VP16 of Herpes Simplex Virus. One line,
the transactivator (TA), harbors the transgene encoding VP16
under the control of a developmentally regulated promoter from
the Hoxc8 gene. The other line, the transresponder (TR), harbors
a Hox transgene under the control of an immediate early
promoter of HSV. Activation of the immediate early promoter
of the transresponder transgene requires the presence of VP16
protein. Crosses of TA and TR for the Hoxd4-transgene result in
two genotypes (TA/++ /+ and TA/+ TR/+), while the Hoxc8-
transgene crosses produce four genotypes (TA/++ /+, TA/TA
+/+, TA/+ TR/+, and TA/TA TR/+). In the results presented
here, we identify only two genotypes: the control genotype (TA)
containing at least one TA and no TR, and the experimental
genotype (TA+TR) containing at least one TA and one TR. DNA
isolated from tails of individual animals was used for genotyping by
semi-quantitative PCR [4,10].
Preparation of Primary Chondrocytes from Transgenic
Mice
The dissection of rib cages, at 18.5 days of gestation, and
purification of chondrocytes were done exactly as described earlier
[5,11]. Cells were transferred into Trizol reagent (Invitrogen,
Carlsbad, CA, USA) and RNA was extracted as described in
Kruger et al. (2006) [5]. Complementary DNA was obtained by
reverse transcription (1
st Strand Synthesis System for RT-PCR,
Invitrogen) from maximally 5 mg RNA of each sample, following
the supplier’s instructions. Purification of cDNA was carried out
using QIAquickH PCR purification columns (Qiagen, Valencia,
CA, USA). RNA as well as cDNA concentrations were measured
with a NanoDropH ND-1000 Spectrophotometer (NanoDrop
Technologies, Inc., Rockland, DE, USA).
Primers
Primers for amplification were designed according to the
parameters described in Kruger et al. (2006) [5]. Primers for the
gene encoding Glyceraldehyde phosphate dehydrogenase (Gapdh)
were used as provided by Applied Biosystems (Foster City, CA).
The locations and sequences of primers are listed in Table 1.
Where possible, the expected product amplicon was designed to
span an exon/exon junction to avoid amplification from
potentially contaminating genomic DNA. The ENSEMBLE
genome browser contains the transcript and exon information
for the genes investigated here (accession numbers are given in
Table 1).
Quantitative Real-Time PCR
Using the ABI Prism 7000 Instrument (Applied Biosystems,
Foster City, CA, USA), gene expression was evaluated in
chondrocyte preparations from individual mice belonging to
several independent families of Hoxc8- and Hoxd4-transgenic
mice and their non-transgenic littermates. Each PCR reaction
(25 ml) was performed on 4 ng of cDNA template in 12 mlo f
water, 0.25 ml of each primer solution (10 mM) and 12.5 mlo f
SYBR Green Master Mix (Applied Biosystems). The thermal
cycling reaction starts with 2 minutes at 50uC and 10 minutes at
95uC for optimal DNA polymerase activation. The PCR reactions
consisted of a denaturation step of 15 seconds at 95uC, annealing
and extension for one minute at 60uC, for a total of 40 cycles.
Analysis was performed with ABI Prism 7000 SDS Software
Version 1.0. Measurements were done in triplicates and obtained
values were averaged. The Gapdh gene was chosen as a reference
gene for normalization, since its expression levels are comparable
between control and transgenic samples; comparisons to other
commonly used reference genes, such a cyclophilin or Pole4
confirmed the uniformity of expression levels in different
experimental groups for the Gapdh reference. Applying the
formula CTgene2CTGapdh=DCT normalized each gene to mea-
surements for Gapdh cDNA in the same sample. Comparison of
transgenic samples to non-transgenic littermate controls was
achieved in a second subtraction, which yielded the DDCT values:
DDCT=DCTtransgenic2DCTcontrol. Amplification efficiencies were
determined for each gene-specific reaction from the slope of the
linear portion of the amplification reaction. The efficiencies and
amplification rates shown in Table 1 were calculated as previously
described [5] from at least 11 independent samples for each gene.
The amplification of the target gene and the endogenous control
occurred in separate tubes. To use the comparative CT method,
we ascertained that the efficiencies of the target and endogenous
control amplifications were approximately equal. To calculate the
fold-change of expression levels, we averaged DCT values for
transgenic and control groups, respectively (6 SEM). Thus, graphs
representing fold-change data do not contain standard deviations.
To estimate the ‘‘relative fold-change’’, we used the formula
f=r
DDCT (absolute DDCT value), with r representing amplification
rate (r=amplification efficiency e+1).
Statistical Evaluation
For statistical analyses, we used the Data Analysis Pack module
implemented in Microsoft Excel X as well as GraphPad PRISMH
(GraphPad Software, San Diego, USA). Two-tailed Student’s T-
tests with 95% confidence intervals were performed to analyze
differences in gene expression between the controls and TR-
containing transgenic mice. Coefficients for the correlation
between Hox gene expression levels and expression levels of
investigated genes (Table S1) were calculated based on DCT
values. The correlation coefficient r is dimensionless and ranges
from 21.0 to 1.0, with 21.0 representing a strong negative, and
1.0 a strong positive linear relationship. We set an arbitrary cut-off
at |0.6| for considering an r-value as correlated.
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In order to determine whether expression of genes in the
chondrocyte differentiation and maturation pathways was altered
in Hoxc8- or Hoxd4-transgenic mice, we assayed the prevalence of
transcripts for genes known to participate in regulation of the
chondrocyte differentiation pathway. Quantitative real-time PCR
was performed on cDNA samples derived from RNA isolated from
primary chondrocytes of individual rib cartilages from Hoxc8- and
Hoxd4-transgenic mice, respectively. In earlier published work
[3,4,10], we demonstrated that the Hoxc8- and Hoxd4-transgenes
are specifically activated in chondrocytes in our transgenic mice.
Both transgenes are reproducibly overexpressed in respective
transgenic cells prior to birth [5]. In the samples used for the
present study, Hoxc8 expression levels were 5.29-fold higher in
Hoxc8-transgenic primary rib chondrocytes compared to their
littermate controls, and Hoxd4 expression levels were 17.22-fold
higher in Hoxd4-transgenic cartilage, compared to their littermate
controls. The magnitude of Hoxd4 transgene expression appears
higher than for the Hoxc8 transgene because there is virtually no
Hoxd4 expressed in non-transgenic rib chondrocytes, while Hoxc8
is normally expressed in ribs.
We investigated gene expression levels in at least 5 individual
control and 5 TR-containing samples (from at least 3 families each)
of our Hoxc8- and Hoxd4-transgenic lines, respectively (Table 2).
The results are plotted as DCT (expression level for each gene
normalized to Gapdh) relative to the corresponding DCT values for
Hoxc8 or Hoxd4 gene expression the same sample. Each data point
represents the average of triplicate measurements for an individual
animal. Lower DCT values indicate higher gene expression level;
higher DCT values correspond to lower expression level. TR
containing animals (Figure 1A, 1B: red filled rectangles) always had
a lower DCT value for the expression of the Hoxc8- or Hoxd4-
transgene compared to the respective littermate controls (Figure 1A,
1B: open white rectangles), clearly indicating higher levels of Hox
gene expression in the respective transgenic samples. Low DCT
values, such as for Prl1, Sox9, Pfn1 and ß-Catenin indicate high
overall expression levels, and conversely, high DCT values for Fgf8,
Fgf10, Mmp3, Tcfap2a, or Wnt3a indicate that expression of these
genes is very low in primary chondrocytes under normal conditions.
Genes with intermediate level of expression are Bmpr1a, Bmpr2,
Ihh, Runx2,Runx3,Sox6 and Wdr5.Close clustering ofdatapoints
for each gene along the X-axis dimension demonstrates low
variability of measurements between individual animals.
Gene Expression in Hoxc8-Transgenic Chondrocytes
The comparison of chondrocyte pathway gene expression between
Hoxc8-transgenic and control animals revealed significant differences
(p,0.05) for the DCT values of Bmp4, Fgf8, Fgf10, Mmp9, Mmp13,
Nos3, Timp3, Wnt3a and Wnt5a (bold in Figure 1A). Except for
Wnt3a, all these genes show decreased expression levels in transgenic
chondrocytes compared to their littermate controls (Figure 2A). After
normalizing to Gapdh, our endogenous reference gene, the fold-
change was calculated using the comparative CT method including
the correction for amplification rate (Figure 2B). An increased level
was found for Wnt3a with overall 5.6-fold (after amplification rate
correction) elevated expression in transgenic samples compared to
controls. The expression levels of Mmp13 and Fgf10 were more than
2-times lower in Hoxc8-transgenic animals compared to controls.
Decreased expression levelsof around 1.8-foldwere found for Mmp9,
Nos3 and Fgf8, and 1.5-fold lower expression for Bmp4 and Wnt5a
(Figure 2B). A significant decrease of expression by 1.4-fold was
observed for Timp3 in chondrocytes from Hoxc8-transgenic animals
compared to controls. Thus, expression levels of Bmp4, Fgf8, Fgf10,
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PLoS ONE | www.plosone.org 4 February 2010 | Volume 5 | Issue 2 | e8978Mmp9, Mmp13, Nos3, Timp3, Wnt3a and Wnt5a were significantly
altered in primary chondrocytes from Hoxc8-transgenic mice.
Gene Expression in Hoxd4-Transgenic Chondrocytes
In Hoxd4-transgenic chondrocytes, 33 of the 37 tested genes
showed no significant differences in mRNA expression levels
relative to controls, while 4 genes exhibited altered expression
(Figure 2C). Wnt3a exhibited the greatest difference in DCT
values, in addition to Mmp8, Fgfr3 and Ihh, compared to controls
(Figure 2D) (p,0.05). The expression levels of Wnt3a were 2.8-
fold lower in Hoxd4-transgenic chondrocytes compared to
controls. Mmp8 expression levels were increased 1.7-fold in
transgenic animals compared to controls, and we found moder-
ately (by 1.4- and 1.3-fold, respectively) but significantly elevated
Table 2. Gene expression in Hoxc8 and Hoxd4 transgenic animals normalized to Gapdh.
Gene Control Hoxc8-transgenic Control Hoxd4-transgenic
TA only TA + TR P-value TA/ /+ +/+ TA/ /+ TR/ /+ P-value
Bmp4 7.0860.26 (n=9) 7.8360.19 (n=13) 0.028 8.6160.06 (n=9) 8.8460.14 (n=12) 0.220
Bmpr1a 4.4160.36 (n=5) 4.7560.14 (n=6) 0.356 5.4360.08 (n=6) 5.4560.07 (n=5) 0.834
Bmpr1b 9.6560.45 (n=5) 10.5160.29 (n=6) 0.131 10.1960.18 (n=6) 10.3360.14 (n=5) 0.584
Bmpr2 5.6460.29 (n=5) 5.7660.11 (n=6) 0.700 5.9060.12 (n=6) 5.7660.06 (n=5) 0.344
ß-Catenin 1.5460.29 (n=5) 1.9760.09 (n=6) 0.158 2.5460.08 (n=6) 2.4560.05 (n=5) 0.375
Cbf-ß 4.0060.30 (n=5) 4.5160.07 (n=6) 0.101 4.2960.25 (n=2) 4.5760.09 (n=8) 0.244
Col2a 2.8760.29 (n=5) 3.0960.24 (n=6) 0.574 3.5560.25 (n=14) 3.1060.22 (n=18) 0.185
Ext1 4.3360.30 (n=4) 4.8560.12 (n=6) 0.103 3.6060.15 (n=3) 3.6560.09 (n=8) 0.804
Fgf8 13.1860.23 (n=5) 14.0560.27 (n=6) 0.039 12.8060.36 (n=6) 12.6460.56 (n=5) 0.809
Fgf10 11.5560.19 (n=5) 13.2060.54 (n=6) 0.026 12.9260.46 (n=6) 13.5360.29 (n=5) 0.315
Fgf18 9.2760.40 (n=5) 10.4560.74 (n=6) 0.219 11.0760.24 (n=6) 11.9960.47 (n=5) 0.099
Fgfr1 2.8760.27 (n=9) 3.1260.10 (n=13) 0.336 3.8360.09 (n=6) 3.6760.10 (n=5) 0.293
Fgfr2 4.2760.34 (n=5) 4.6460.19 (n=6) 0.344 5.3160.14 (n=6) 5.2960.04 (n=5) 0.887
Fgfr3 2.8960.16 (n=8) 3.1260.11 (n=13) 0.238 3.6060.27 (n=6) 2.8860.05 (n=5) 0.044
Fgfr4 4.9760.18 (n=5) 5.2060.16 (n=6) 0.361 5.1360.05 (n=6) 4.9460.15 (n=5) 0.230
Hoxc8 2.9860.19 (n=24) 0.2460.15 (n=38) ,0.001
Hoxd4 15.5360.51 (n=21) 5.5560.12 (n=24) p,0.001
Ihh 5.6960.25 (n=5) 6.2860.14 (n=6) 0.059 5.7160.21 (n=6) 5.0860.13 (n=5) 0.039
Lrp5 5.8460.21 (n=9) 5.7160.11 (n=13) 0.550 6.6360.18 (n=6) 6.3060.07 (n=5) 0.148
Lrp6 5.9460.12 (n=9) 6.1460.13 (n=13) 0.275 6.3360.11 (n=6) 6.2060.05 (n=5) 0.332
Mmp3 14.7760.36 (n=5) 15.1560.46 (n=6) 0.551 15.4860.28 (n=9) 15.1160.39 (n=12) 0.480
Mmp8 9.4360.66 (n=15) 10.2960.36 (n=21) 0.231 10.7960.28 (n=8) 9.8460.30 (n=11) 0.038
Mmp9 8.5160.46 (n=15) 9.4260.23 (n=20) 0.007 10.1760.24 (n=12) 10.0260.28 (n=20) 0.729
Mmp13 7.0660.54 (n=9) 8.7160.29 (n=13) 0.006 10.3260.24 (n=12) 10.9760.30 (n=20) 0.143
Nos3 9.4860.16 (n=5) 10.3860.24 (n=6) 0.015 9.8160.23 (n=6) 9.9360.08 (n=5) 0.661
Pfn1 20.0360.27 (n=5) 0.3660.20 (n=6) 0.265 1.6160.30 (n=9) 1.3460.0.27 (n=13) 0.520
Prl1 0.3760.20 (n=8) 0.4460.15 (n=17) 0.878 0.2060.14 (n=8) 0.4660.14 (n=9) 0.219
Pthlh 9.4560.38 (n=9) 9.6060.21 (n=13) 0.720 10.8760.21 (n=9) 10.8860.16 (n=14) 0.975
Runx2 4.9260.26 (n=5) 5.2460.15 (n=6) 0.288 6.3760.52 (n=9) 5.5960.28 (n=13) 0.167
Runx3 7.4460.37 (n=5) 7.7060.33 (n=6) 0.624 7.3160.33 (n=9) 7.0160.17 (n=12) 0.392
Sox5 3.9660.16 (n=2) 3.9660.11 (n=7) 0.998 3.9160.07 (n=6) 3.7560.10 (n=5) 0.228
Sox6 5.4360.27 (n=2) 5.4360.08 (n=6) 0.981 5.2260.10 (n=6) 5.0560.05 (n=5) 0.183
Sox8 2.1761.10 (n=8) 3.4360.78 (n=13) 0.350 4.4260.21 (n=9) 4.4160.07 (n=13) 0.934
Sox9 2.7760.25 (n=8) 3.0560.11 (n=14) 0.264 1.8060.43 (n=9) 0.9260.24 (n=13) 0.070
Tcfap2a 12.6860.23 (n=5) 13.2960.42 (n=6) 0.101 12.7760.10 (n=2) 13.4260.25 (n=8) 0.244
Timp3 4.4160.28 (n=9) 5.0660.16 (n=13) 0.045 5.3260.19 (n=6) 4.8460.30 (n=5) 0.199
Wdr5 4.8960.28 (n=5) 5.2060.11 (n=6) 0.301 6.3060.07 (n=6) 6.2460.14 (n=5) 0.678
Wnt3a 12.8561.05 (n=8) 9.3161.18 (n=10) 0.052 12.360.47 (n=5) 14.4260.44 (n=5) 0.011
Wnt5a 7.9860.18 (n=5) 8.8560.22 (n=6) 0.016 8.4060.19 (n=6) 8.2560.17 (n=5) 0.565
DCT values were determined for all controls (TA only) and TR-containing Hoxc8- and Hoxd4-transgenic samples. Means (6 standard error of the mean) were calculated
for all individuals tested in each group (n= from 2 to 21) as indicated. P-values were obtained by performing two-tailed Student’s T-tests.
doi:10.1371/journal.pone.0008978.t002
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expression levels of Fgfr3, Ihh, Mmp8 and Wnt3a as significantly
altered in primary chondrocytes from Hoxd4-transgenic mice.
Relationship of Gene Expression to Transgene Levels
It remains to be investigated whether the differential gene
expression levels in the cartilage of Hoxc8- and Hoxd4-transgenic
animals are proximally causal to the cartilage defects, or whether
they are distal indicators of abnormal differentiation caused by
overexpression of the transcription factors. In order to address this
question, we determined the correlation between gene expression
levels and the levels of transgene expression in individual animals
(data provided in Table S1). Our expectation was that for possible
direct targets of the Hox transcription factors, their expression
would be either strongly stimulated or repressed by the respective
transgene, and hence, expression values would be expected to
exhibit a strong positive or inverse correlation to transgene
expression levels in the same animals. Meaningful correlations
between expression of the respective gene and Hoxc8 were found
for 20 genes: Positive correlation exists for Bmpr1b and Mmp3 in
controls and Hoxc8-transgenic samples, and a consistent negative
correlation was found for Fgfr4, indicating a potential repressive
action of Hoxc8. However, neither of these genes alters expression
levels in response to higher Hoxc8 levels (see Table 2) and they are
thus unlikely to be directly regulated by Hoxc8. Strong
correlations with Hoxc8 expression levels for Bmpr1a, Bmpr2,
ß-Catenin, Cbf-ß, Ext1, Fgf8, Fgf18, Fgfr2, Runx3, Sox8, Sox9,
Wdr5 and Wnt3a in controls are lost upon expression of the
transgene, suggesting that transgene expression perturbs regulato-
ry mechanisms for these genes. A gain of correlation of gene
expression levels is detected for Nos3, Col2a and Wnt5a, with the
latter two exhibiting an inverse relationship to Hoxc8 levels.
However, Hoxc8 overexpression at the same time is correlated to
lower levels of Nos3, excluding a direct link; in transgenic cells, the
transcription factor interferes with Nos3 expression possibly
through indirect mechanisms. A complex regulatory involvement
for Hoxc8 in gene expression is indicated by the reversal by Hoxc8
overexpression in the direction of correlation for Profilin1 and
Runx2 expression. Wnt5a expression is also inversely correlated to
Hoxc8, suggesting a repressive relationship, and this is borne out
by reduced Wnt5a levels in Hoxc8-transgenic chondrocytes.
For Hoxd4, the analysis indicates positive correlations for Fgfr4,
Ihh, Sox5, Sox6 and Timp3, which are lost in the transgenic
condition. For ß-Catenin and Wdr5, the strong correlation to
Hoxd4 expression found in controls incurs reversal to inverse
correlation in Hoxd4-transgenic samples; gain of a negative
correlation in the transgenic condition was observed to Bmpr1a
and Bmpr1b, and of a positive correlation for Fgf10 and Fgf18.
Yet, there are no significant changes of expression level of these
Figure 1. Gene expression in Hoxc8- and Hoxd4-transgenic
chondrocytes. Quantitative real-time PCR was performed in triplicate
on cDNA prepared from mRNA that was isolated from primary rib
chondrocytes. Rib cages were dissected at 18.5 days of gestation from
individual Hoxc8- (A) and Hoxd4- (B) transgenic mouse embryos.
G a p d hc D N Al e v e l si ne a c hs a m p l ew e r eu s e dt os t a n d a r d i z e
measurements. The results are plotted as Gapdh-normalized DCT values
for each gene relative to Gapdh-normalized Hoxc8 or Hoxd4 gene
expression (DCT) in each sample. Low DCT values reflect higher relative
expression levels, and high DCT values reflect low relative levels of gene
expression. Each dot represents an individual animal (filled symbol =
TR-containing samples, open symbol = controls). Bold panel labeling
indicates statistical significant differences in expression levels between
transgenic and control groups.
doi:10.1371/journal.pone.0008978.g001
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suggests that the relationship between transcription factor levels
and gene expression levels is complex.
Discussion
Our data demonstrate that mRNA expression levels of
particular genes are affected by overexpression of either Hoxc8
or Hoxd4 transcription factors in cartilage. These outcomes were
measured in chondrocytes prepared on gestational day 18.5, just
prior to birth. Thus, in order to interpret these results, we have to
consider their relation to the process of cartilage formation during
development.
Limited gene expression studies performed by quantitative real-
time PCR on Hoxc8-transgenic rib chondrocytes were published
by Cormier et al. (2003) [11], who compared gene expression
levels in transgenic samples to FVB inbred mice as controls. Here,
we compare gene expression levels from Hoxc8- (TA+TR) and
Hoxd4-(TA/+ TR/+)-transgenic chondrocytes to controls (TA
only and TA/++ /+, respectively) from the same litter. In this way,
any potential influence from the maternal environment should be
excluded, since controls and experimental embryos were raised in
the same dam. Differences in maternal effects between FVB
control pregnancies and pregnancies from transgenic crosses might
account for the differences of earlier results to the present study.
Discrepancies might be further traced to sample preparation: in
this study, RNA was extracted from single rib cages from animals
at 18.5 days of gestation, whereas the earlier study prepared
postnatal rib chondrocytes from newborns between birth and up
to 2 days of age. In addition, the earlier study used poly-A+
enriched mRNA, and given the low expression levels of some of
our test genes in chondrocytes, the generally low yield of this
procedure may have introduced substantial variation. Finally, the
earlier study used pools of cDNAs while the current measurements
were done on individual samples. Because we find very small
variations between technical replicates of the same sample, we feel
confident about the reliability of the results presented here.
This comprehensive gene expression study on Hoxc8- and
Hoxd4-transgenic primary chondrocytes revealed a few genes to
be deregulated at the transcriptional level. Gene expression levels
of eight genes (Bmp4, Fgf8, Fgf10, Mmp9, Mmp13, Nos3, Timp3,
and Wnt5a) were significantly decreased in Hoxc8-transgenic
animals, and Wnt3a expression was significantly increased. In
Hoxd4-transgenic animals, elevated levels of Fgfr3, Ihh, Mmp8,
and decreased levels of Wnt3a were detected. These results suggest
that cartilage defects in Hoxc8- or Hoxd4-transgenic mice, while
similar at the morphological level, may be based on different
molecular mechanisms. They also identify these genes as plausible
candidate targets for regulation by the respective Hox transcrip-
tion factor.
Figure 2. Altered gene expression levels in Hoxc8- and Hoxd4-transgenic cartilage. DCT values (normalized to endogenous control
Gapdh) were averaged for each investigated gene over the control group as well the Hoxc8-transgenic group (A,C) and the Hoxd4-transgenic group
(B,D), respectively, and are plotted as mean 6 standard error of the mean (SEM). Student’s T-test was performed to confirm statistical significance
(p,0.05). Higher DCT values were found for Bmp4, Fgf8, Fgf10, Mmp9, Mmp13, Nos3, Timp3, and Wnt5a (A, filled bars) in Hoxc8-transgenic animals,
indicating lower expression levels compared to littermate controls (A, open bars). Wnt3a expression was higher (lower DCT value) in Hoxc-transgenic
chondrocytes compared to controls. Lower DCT values were found for Fgfr3, Ihh and Mmp8 (B, filled bars) in Hoxd4-transgenic animals, indicating
higher expression levels compared to littermate controls (B, open bars). Wnt3a expression levels are lower in Hoxd4-transgenic chondrocytes (higher
DCT value) compared to the control group. Figures C and D present the relative fold-change using the comparative CT method based on
amplification efficiency for each gene (see Methods), respectively.
doi:10.1371/journal.pone.0008978.g002
Cartilage Gene Expression
PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e8978Bone Morphogenetic Proteins
Several genes are described in the literature that pattern
distribution and proliferation of mesenchymal cells in conden-
sation sites for future skeletal elements and therefore are
important for limb and rib development [1,12,13]. During the
events of chondrogenesis, Wnt, Fgf and Bmp signals are among
the earliest signals [14]. BMPs, in addition to initiating
chondroprogenitor cell determination and differentiation, also
regulate later stages of chondrocyte maturation. Since Bmp4 is
known to have a positive effect on hypertrophy [15], decreased
expression level of Bmp4 in our Hoxc8-transgenic chondrocytes
could be responsible for the observed delay in maturation in
these cells [4]. Whether Hoxc8 itself directly deregulates BMP4
expression or whether other factors are involved warrants
further investigation.
Hedgehog Signaling
Ihh is involved in chondrocyte differentiation, proliferation and
maturation during endochondral ossification. There is evidence
that Ihh decreases the rate of progression to hypertrophy [16,17].
Ihh is expressed in prehypertrophic chondrocytes and is involved
in a negative feedback loop at the level of hypertrophic cells [18].
In this feedback scheme, Ihh stimulates synthesis of Parathyroid
hormone-like hormone (Pthlh, formerly known as Pthrp) in the
periarticular region of the growth plate, which then delays
differentiation of proliferating chondrocytes into hypertrophic
chondrocytes, which express Ihh mRNA [19]. Thus, chondrocyte
hypertrophy is regulated through the interplay of Ihh and Pthlh
signaling, and this regulation also involves Fgfs and Bmp signaling
[8]. On the other hand, Ihh also has signaling functions
independent of Pthlh [20]. Hoxd4-transgenic rib cage chondro-
cytes exhibit elevated Ihh expression compared to controls, but no
change in Pthlh expression levels. Thus, for Hoxd4-transgenic
chondrocytes, it is possible that elevated Ihh expression contributes
to the observed phenotypes of delayed chondrocyte maturation
and increased persistence of immature cells in the Hox transgenic
cartilage, but likely this would be independent of the Pthlh
feedback loop.
Fibroblast Growth Factors
FGF signaling pathways are important regulators of chondro-
genesis. Experimental studies in mice and cell culture show that
signaling through Fgfr3 inhibits chondrocyte proliferation [21].
Mutations of this receptor cause a range of human bone disorders
[22]. Targeted deletion of Fgfr3 in mice leads to increased regions
of proliferating and hypertrophic chondrocytes [23,24]. These
findings at late gestational and postnatal stages of mouse
development have led to the conclusion that Fgf signaling through
this receptor is to limit chondrocyte proliferation and differenti-
ation [25]. To date, only Fgf18 is discussed as a candidate for a
ligand that signals through Fgfr3, based on the phenotype and
expression pattern of Fgf18 null mice as well as on studies in vitro,
where Fgf18 can stimulate the proliferation of cultured articular
chondrocytes [26,27].
In Hoxd4-transgenic chondrocytes, we found elevated gene
expression of Fgfr3, while the Fgfs we investigated (Fgf8, Fgf10
and Fgf18) were not deregulated. Increased Fgfr3 signaling
activity would be expected to further limit chondrocyte differen-
tiation compared to controls, and thuscould be responsible for the
delayed chondrocyte maturation observed in the Hoxd4-trans-
genic animals. In contrast, in Hoxc8-transgenic chondrocytes,
gene expression of Fgf8 and Fgf10 was found to be decreased, but
no changes in expression levels of Fgf receptors were detected.
Fgf8 signaling is required for the development of distal cartilage
elements in the limb in chick embryos [28], indicating that Fgf8
promotes the process of proliferation and differentiation of
mesenchymal cells into chondrocytes. Fgf10-deficient mice
exhibit a complete truncation of fore and hind limbs [29], also
supporting a role for Fgf10 in promoting chondrocyte prolifer-
ation, although in vitro studies of cultured murine cartilage cells
from the ventral rib cage showed no discernable response to
exogenously administered Fgf10 [30]. Nevertheless, the decrease
in expression levels of Fgf8 and Fgf10 in Hoxc8-transgenic
chondrocytes is consistent with a possible role in the phenotype
we observe in these animals. It is interesting to note that the Fgf
signaling pathway appears to be differentially affected by
overexpression of Hoxc8 versus Hoxd4 transcription factors in
chondrocytes, in that either the receptor or the growth factors are
deregulated, but not both, by the same transgene. These results
suggest that the two transcription factors, despite apparently
similar phenotypic effects on cartilage formation, may regul-
ate different transcriptional targets in chondrocytes or their
progenitors.
Matrixmetalloproteases and Tissue Inhibitor of
Metalloproteases 3
A key process in endochondral ossification is the degradation of
extracellular matrix (ECM) (for review, see Ortega et al. [31]).
Matrixmetalloproteases (MMPs) are a large family of endopepti-
dases that are involved in degradation of many different
components of the ECM, such as Collagen II, Collagen X and
Aggrecan [32,33]. MMPs are produced by a many different cell
types, including epithelial cells, fibroblasts, inflammatory cells, and
chondrocytes.
MMP13 (formerly known as Collagenase 3) is highly expressed
during endochondral ossification; it is required for the transition
from cartilage to bone at the growth plate of long bones [34,35].
MMP13 actively degrades type II collagen, the major type of
collagen in immature cartilage. During endochondral ossification,
MMP13 is expressed in the lower zone of hypertrophic
chondrocytes, co-localized with type X Collagen [36]. MMP9
(formerly known as Gelatinase B) is a key regulator of apoptosis of
hypertrophic chondrocytes [37]. Although both MMPs are
expressed in non-overlapping cell types, they act together in
primary and secondary ossification. Gene expression levels of
Mmp9 as well as Mmp13 were found significantly decreased in
our Hoxc8-transgenic chondrocytes, which could lead to reduced
ECM degradation. Additionally, MMP-mediated processes, such
vascular invasion and chondrocyte apoptosis, might be disturbed
or delayed based on lower expression levels of these genes.
Reduced expression of Mmp9 and Mmp13 in Hoxc8-transgenic
chondrocytes would be consistent with a delay in chondrocyte
maturation and ossification, and thus might be responsible for the
cartilage immaturity phenotype we observe in Hoxc8-transgenic
mice.
In contrast, in Hoxd4-transgenic chondrocytes, we found
Mmp8 expression to be elevated. Mmp8 (formerly known as
Collagenase 2) is implicated in tissue remodeling under inflam-
matory conditions, and in wound healing [38,39,40]. Mmp8 was
also reported to be expressed in mandibular and hind limb
chondrocytes [41], and our results demonstrate it to be expressed
in rib chondrocytes. The functional role of Mmp8 in chondro-
genesis is currently unknown.
The activity of MMPs is regulated by the four members of the
Tissue Inhibitor of Metalloproteinases (TIMP) family, which are
mainly expressed by chondrocytes and bone-lining cells [42].
TIMP3 localizes to the ECM and inhibits MMP9, among other
MMPs [43,44]. Inhibition occurs when the active site of the
Cartilage Gene Expression
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TIMP protein, and a normal balance between MMPs and TIMPs
is important for matrix remodeling and tissue architecture [45].
We found Timp3 expression decreased in Hoxc8-transgenic
chondrocytes; it is intriguing to note that this coincides with
decreased expression of Mmp9 and Mmp13. These results suggest
that matrix maintenance and remodeling may be altered in
Hoxc8-transgenic cartilage.
Nitric Oxide Synthase 3
Nos3 encodes the murine endothelial Nitric oxide synthase,
located on mouse chromosome 5 [46]. NO (nitric oxide) is known
to mediate physiological responses in the nervous system, immune
system and vascular smooth muscle. It has been reported that NO
produced by eNOS and iNOS in osteoblasts and osteoclasts
influences bone growth and remodeling [47,48]. Studies in chick
growth plate chondrocytes indicate that NO metabolism is
required for development of the mature chondrocyte phenotype:
it stimulates hypertrophy and seems to promote apoptosis of
terminally differentiated chondrocytes [49]. NO also stimulates
MMP production and activity in osteoarthritic joint cartilage [50].
The occurrence of limb reduction defects in Nos3-deficient mice
[51] demonstrates a crucial role of NOS3 for normal bone
development. Thus, it is tempting to speculate that lower
expression of MMPs in Hoxc8-transgenic chondrocytes could be
due to reduced NO production associated with lower Nos3
expression levels.
ß-Catenin and Wnt Signaling
ß-Catenin plays important roles during skeletal development,
and is the molecular node for signal transduction in the canonical
Wnt signaling pathway [52]. Wnt-proteins are thought to bind to
cell-surface receptors of the Frizzed family and activate Dishev-
elled family proteins; in turn, ß-Catenin becomes protected from
proteasome-mediated degradation. Activated/de-phosphorylated
ß-Catenin enters the nucleus and promotes the activation of target
genes by interaction with TCF/LEF family of transcription
factors. While in both Hoxc8- and Hoxd4-transgenic chondro-
cytes ß-Catenin expression was not altered at the transcriptional
level, Wnt3a exhibited decreased expression levels in Hoxd4-
transgenic rib cage chondrocytes. This reduced Wnt3a ligand
expression and hence, reduced signaling, could be involved in
delayed chondrocyte maturation in mice with Hoxd4 overex-
pression. On the other hand, we found Wnt3a expression levels
elevated in Hoxc8-transgenic chondrocytes. Since Wnt3a pro-
motes cell proliferation in many tissue systems, higher Wnt3a
levels would be consistent with accumulation of proliferating cells
in Hoxc8-transgenic cartilage. The most intriguing finding,
however, is that Wnt3a levels are misregulated in opposite
direction in Hoxc8- versus Hoxd4-transgenic chondrocytes, again
providing evidence for the notion that both transgenes are
involved in distinct pathways in the respective transgenic
cartilage.
Wnt5a is expressed in proliferating and prehypertrophic
chondrocytes and plays a pivotal role during chondrocyte
proliferation and differentiation [53]. Chondrocyte differentiation
was found delayed in developing long bones in Col2a1-Wnt5a
transgenic mice, where Wnt5a is expressed in proliferating and
immature chondrocytes under control the of the Col2a1 promoter
[54]. Experiments in chicken also reveal a delay in maturation
from proliferative to hypertrophic chondrocytes by overexpression
of Wnt5a [55,56,57]. Long-term micromass cell cultures in vitro
confirm that Wnt5a overexpression is associated with a delay in
maturation of chondrocytes [58]. Wnt5a mouse mutants also show
a delay in chondrocyte progression to hypertrophy, and as a
consequence, limbs are shorter in Wnt5a
2/2 mutants [54]. Thus,
conditions of both overexpression and loss of Wnt5a resulted in
altered proliferation of chondrocytes. We found Wnt5a expression
decreased in Hoxc8-transgenic chondrocytes, consistent with a
delay in maturation to hypertrophy. This, combined with the
consistent negative correlation of Wnt5a expression to Hoxc8
expression levels, makes Wnt5a an excellent candidate for
a transcriptional target of Hoxc8 in chondrocytes or their
progenitors.
Conclusions
By targeted investigation of 37 candidate genes, we found
altered expression in transgenic cartilage of several genes that are
known regulators of cartilage development. These genes could
therefore be responsible for the cartilage defects observed in
Hoxc8- and Hoxd4-transgenic animals, respectively. Strikingly,
the subset of genes deregulated in Hoxc8-transgenic cartilage
differs from the group of genes deregulated in Hoxd4-transgenic
cartilage, indicating that different molecular pathways may be
responsible for seemingly similar phenotypic outcomes, namely
delayed chondrocyte proliferation and maturation. Nevertheless,
our study identifies several genes that respond to altered Hoxc8 or
Hoxd4 gene dosage, respectively, and thus might be targets of
these transcription factors in chondrocytes or their progenitors.
Further research will be needed to define the temporal sequence of
changes in gene expression during chondrocyte differentiation,
and to understand how Hox transcription factors and the
deregulated genes we identified here interact to regulate
chondrogenesis.
Supporting Information
Table S1 Correlation between gene expression and transgene
levels in Hoxc8- and Hoxd4-transgenic chondrocytes. The
relationship of gene expression levels to transgene levels in
individual animals was assessed using the Pearson’s correlation
coefficient (r) between DCT values, which are normalized to the
reference gene. A correlation coefficient close to 1.0 indicates a
strong positive relationship, r close to 0 indicates lack thereof, and
negative r indicates an inverse relationship between transgene and
candidate gene levels. Sample numbers smaller than 3 were
excluded from consideration. Bold font indicates strong positive
or negative correlation (r.|0.6|) of gene expression to transgene
levels in control and/or transgenic individuals: black: strong
correlation in controls and transgenics; green: lack of correlation
in control but gain of strong correlation with expression of the
respective transgene; red: strong correlation in controls but loss
with expression of the respective transgene; blue: strong
correlations in opposite directions in controls and transgenic
samples.
Found at: doi:10.1371/journal.pone.0008978.s001 (0.05 MB
DOC)
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